Barclays PLC Retractable Technologies Inc Transaction History

Barclays PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.39 - $4.69 $18,987 - $26,268	-5,601 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.3 - $7.26 $66,400 - $112,108	-15,442 Reduced 73.38%	5,601 $26,000
Q4 2021 Feb 14, 2022	BUY	$6.74 - $10.69 $94,076 - $149,211	13,958 Added 197.01%	21,043 $146,000
Q3 2021 Nov 09, 2021	BUY	$10.3 - $13.45 $33,691 - $43,994	3,271 Added 85.76%	7,085 $78,000
Q2 2021 Aug 13, 2021	SELL	$8.84 - $12.46 $67,758 - $95,505	-7,665 Reduced 66.77%	3,814 $44,000
Q1 2021 May 13, 2021	BUY	$11.15 - $21.5 $79,700 - $153,682	7,148 Added 165.04%	11,479 $148,000
Q4 2020 Feb 11, 2021	SELL	$6.7 - $15.02 $11,966 - $26,825	-1,786 Reduced 29.2%	4,331 $46,000
Q3 2020 Nov 12, 2020	SELL	$5.42 - $13.1 $6,558 - $15,851	-1,210 Reduced 16.51%	6,117 $40,000
Q2 2020 Aug 12, 2020	BUY	$1.25 - $7.38 $9,158 - $54,073	7,327 New	7,327 $52,000
Q2 2018 Aug 14, 2018	SELL	$0.7 - $1.0 $0 - $1	-1 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$0.68 - $1.03 $0 - $1	1 New	1 $0

2.34M

2.7K

100

Ticker RVP
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 32,937,200
Market Cap $26.7M
Description
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adap...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.